What the analyst said

Barclays analyst Tom O’Malley raised the price target on Lam Research (NASDAQ: LRCX) to $255.00 (from $250.00) while maintaining an Equalweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

LRCX trades at $185. The 9 analysts who set a target in the last 3 months range from $290 to $400, with a median of $350. This $255 target is 27% below the median, the lowest on the Street.

Since the note LRCX has moved −12% (from $211). 12-month window: day 240 of 365, closes on March 10, 2027.

Track record

This call✓ Target reached on April 9, 2026, 30 days after the note.

Firm track recordBarclays: 83% of its 40 targets at least a year old were reached within 12 months (#7 of 26 firms). Accuracy ranking →

Barclays on Lam Research

Barclays price targets on Lam Research

5 calls from January 16, 2026 to June 11, 2026. The target went from $195 to $335 (+72%).

Barclays targetLRCX share price
  1. June 11, 2026Target raised from $275 (+22%)$335
  2. April 23, 2026Target raised from $255 (+8%)$275
  3. March 10, 2026 This noteTarget raised from $250 (+2%)$255
  4. January 29, 2026Target raised from $195 (+28%)$250
  5. January 16, 2026Earliest call shown$195
Share

Other analysts on Lam Research

Lynx Equity Kept rating and price target Oct 28 $400maintained BernsteinBuy Cut price target −9%, kept rating Oct 22 $350from $385 UBSBuy Cut price target −6%, kept rating Oct 22 $400from $425 Morgan StanleyBuy Cut price target −12%, kept rating Oct 22 $339from $385 Bank of AmericaBuy Cut price target −10%, kept rating Oct 22 $345from $385
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.